Endometriosis drug shows early promise in targeting disease lesions
A modified medication targets the cells implicated in endometriosis lesions, offering early hope for the condition affecting 190 million people.
This story has stopped developing; this page is its permanent record. More from that day
The story so far
1 publisher has covered this in 1 article since 1 Oct 2026. Nature published first, on 1 October at 00:00 UTC.
No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.
Sources
Every article we clustered into this story. Headlines link to the publisher.